The analysis of differentially expressed genes performed on MCF-7 BC cells after treatment with genistein revealed a strong dose-dependent alteration in the expression of genes involved in cell cycle control, such as glioma pathogenesis-related protein 1 (GLIPR1), cell-division cycle protein 20 homolog (Cdc20), budding uninhibited by benzimidazole 1 (BUB1), mini-chromosome maintenance (MCM) complex 2, and cyclin B1 (CCNB1) [191]. This evidence concerns the gene GLIPR1 and breast cancer.